China Resources Sanjiu Medical & Pharmaceutical Co Ltd Total Liabilities

Latest as of June 2026: CN¥16.71 Billion CNY ≈ $2.45 Billion USD

China Resources Sanjiu Medical & Pharmaceutical Co Ltd total liabilities. Based on the latest financial reports, China Resources Sanjiu Medical & Pharmaceutical Co Ltd (000999) has total liabilities worth CN¥16.71 Billion CNY (≈ $2.45 Billion USD) as of June 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check China Resources Sanjiu Medical & Pharmac asset resilience ratio to evaluate the company's liquid asset resilience ratio.

Total Liabilities of China Resources Sanjiu Medical & Pharmaceutical Co Ltd (1997–2025)

Total liabilities of China Resources Sanjiu Medical & Pharmaceutical Co Ltd from 1997 to 2025. This chart illustrates how China Resources Sanjiu Medical & Pharmaceutical Co Ltd's total liabilities have evolved over time, based on quarterly financial data. Explore China Resources Sanjiu Medical & Pharmac long-term investment allocation to see how much of total assets are deployed in long-term investments.

China Resources Sanjiu Medical & Pharmaceutical Co Ltd Competitors by Total Liabilities

The table below lists competitors of China Resources Sanjiu Medical & Pharmaceutical Co Ltd ranked by their total liabilities.

Company Country Total Liabilities
VSXY
NYSE:VSXY
USA $3.92 Billion
Schaeffler AG
XETRA:SHA0
Germany €18.85 Billion
Bank of Suzhou
SHE:002966
China CN¥809.33 Billion
YANGTZE OPT.FIB.AND CAB.H
F:1YO
Germany €16.63 Billion
Haohua Chemical Science & Technology Corp Ltd
SHG:600378
China CN¥12.95 Billion
Indian Overseas Bank
NSE:IOB
India Rs4.12 Trillion
Inner Mongolia Xingye Mining Co Ltd
SHE:000426
China CN¥8.15 Billion
Hebei Yangyuan ZhiHui Beverage Co Ltd
SHG:603156
China CN¥2.33 Billion

Liability Composition Analysis (1997–2025)

This chart breaks down China Resources Sanjiu Medical & Pharmaceutical Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see China Resources Sanjiu Medical & Pharmac (000999) total assets.

Liquidity & Leverage Metrics

China Resources Sanjiu Medical & Pharmaceutical Co Ltd Total Liabilities Ratios Explained

China Resources Sanjiu Medical & Pharmaceutical Co Ltd total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.

Metric Value Description
Current Ratio 2.02 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.73 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.30 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how China Resources Sanjiu Medical & Pharmaceutical Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for China Resources Sanjiu Medical & Pharmaceutical Co Ltd (1997–2025)

The table below shows the annual total liabilities of China Resources Sanjiu Medical & Pharmaceutical Co Ltd from 1997 to 2025.

Year Total Liabilities Change
2025-12-31 CN¥20.03 Billion
≈ $2.93 Billion
+35.12%
2024-12-31 CN¥14.83 Billion
≈ $2.17 Billion
-6.68%
2023-12-31 CN¥15.89 Billion
≈ $2.32 Billion
+65.67%
2022-12-31 CN¥9.59 Billion
≈ $1.40 Billion
+9.37%
2021-12-31 CN¥8.77 Billion
≈ $1.28 Billion
+8.25%
2020-12-31 CN¥8.10 Billion
≈ $1.19 Billion
-2.69%
2019-12-31 CN¥8.32 Billion
≈ $1.22 Billion
+21.31%
2018-12-31 CN¥6.86 Billion
≈ $1.00 Billion
+13.02%
2017-12-31 CN¥6.07 Billion
≈ $888.35 Million
+25.68%
2016-12-31 CN¥4.83 Billion
≈ $706.84 Million
+11.17%
2015-12-31 CN¥4.35 Billion
≈ $635.83 Million
+18.34%
2014-12-31 CN¥3.67 Billion
≈ $537.29 Million
-2.84%
2013-12-31 CN¥3.78 Billion
≈ $553.01 Million
+23.21%
2012-12-31 CN¥3.07 Billion
≈ $448.85 Million
+11.60%
2011-12-31 CN¥2.75 Billion
≈ $402.19 Million
+47.86%
2010-12-31 CN¥1.86 Billion
≈ $272.01 Million
+10.65%
2009-12-31 CN¥1.68 Billion
≈ $245.83 Million
-1.26%
2008-12-31 CN¥1.70 Billion
≈ $248.98 Million
-65.83%
2007-12-31 CN¥4.98 Billion
≈ $728.65 Million
+10.20%
2006-12-31 CN¥4.52 Billion
≈ $661.19 Million
-2.85%
2005-12-31 CN¥4.65 Billion
≈ $680.58 Million
-4.88%
2004-12-31 CN¥4.89 Billion
≈ $715.53 Million
-6.83%
2003-12-31 CN¥5.25 Billion
≈ $767.97 Million
+35.32%
2002-12-31 CN¥3.88 Billion
≈ $567.51 Million
+6.34%
2001-12-31 CN¥3.65 Billion
≈ $533.65 Million
+29.65%
2000-12-31 CN¥2.81 Billion
≈ $411.63 Million
+203.79%
1999-12-31 CN¥925.96 Million
≈ $135.50 Million
-3.51%
1998-12-31 CN¥959.69 Million
≈ $140.43 Million
+6.96%
1997-12-31 CN¥897.21 Million
≈ $131.29 Million
--

About China Resources Sanjiu Medical & Pharmaceutical Co Ltd

SHE:000999 China Drug Manufacturers - Specialty & Generic
Market Cap
$6.25 Billion
CN¥42.72 Billion CNY
Market Cap Rank
#3004 Global
#341 in China
Share Price
CN¥25.67
Change (1 day)
-0.77%
52-Week Range
CN¥22.16 - CN¥30.53
All Time High
CN¥1328.34
About

China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of pharmaceutical products in the People's Republic of China and internationally. The company offers health consumer products (CHC), including cold, flu, skin, gastrointestinal, cough, orthopedics, pediatrics drugs, and dietary nutritional supplements; and prescription drug prod… Read more